Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, February 1, 2026.
Aktis Oncology, Inc. - Common stock (NASDAQ:AKTS)
Long-Term Downtrend (-90) - AKTS is in a strong downtrend that is likely to continue. While AKTS is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid AKTS?
MarketClub looks at technical strength and momentum to determine if the timing is right for AKTS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for AKTS
The long-term trend has been DOWN since Dec 16th, 2024 at 0.0431
The intermediate-term trend has been DOWN since Dec 16th, 2024 at 0.0606
The short-term trend has been DOWN since Jan 29th, 2026 at 20.0200
Smart Scan Analysis for AKTS
Based on our trend formula, AKTS is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 19.91 | 20.35 | 19.20 | 20.23 | +0.59 |
| Prev. Close | Volume | Bid | Ask | Time |
| 20.25 | 155691 | 2026-01-30 15:59:54 |
| Year High | 9.5 | Year High Date | 2018-07-05 |
| Year Low | 3.4 | Year Low Date | 2018-11-06 |
| 52wk High | 29.16 | 52wk High Date | 2026-01-09 |
| 52wk Low | 18.52 | 52wk Low Date | 2026-01-20 |
| Average Volume | 553,511 | Shares Outstanding | 154,591 |
| Market Cap | 247M | Assets | 57,371,000M |
| Liabilities | 122,586,000M | Volatility | 113.64 |